The sarco-endoplasmic reticulum Ca 2؉ -transport ATPase (SERCA) loads intracellular releasable Ca 2؉ stores by transporting cytosolic Ca 2؉ into the endoplasmic (ER) or sarcoplasmic reticulum (SR). We characterized the only SERCA homologue of the nematode Caenorhabditis elegans, which is encoded by the sca-1 gene. The sca-1 transcript is alternatively spliced in a similar mode as the vertebrate SERCA2 transcript, giving rise to two protein variants: CeSERCAa and CeSERCAb. These proteins showed structural and functional conservation to the vertebrate SERCA2a/b proteins. The CeSERCAs were primarily expressed in contractile tissues. Loss of CeSERCA through gene ablation or RNA interference resulted in contractile dysfunctioning and in early larval or embryonic lethality, respectively. Similar defects could be induced pharmacologically using the SERCA-specific inhibitor thapsigargin, which bound CeSERCA at a conserved site. The conservation of SERCA2 homologues in C. elegans will allow genetic and chemical suppressor analyses to identify promising drug targets and lead molecules for treatment of SERCA-related diseases such as heart disease.
Intracellular organelles play a critical role in the regulation of cytosolic Ca 2ϩ levels by acting both as sinks for removal of Ca 2ϩ from the cytoplasm and as sites of storage for its subsequent release. Ca 2ϩ cycling between the cytoplasm and the sarcoplasmic reticulum (SR) 1 is tightly linked to the contraction-relaxation cycle of myocytes. Contraction occurs upon release of Ca 2ϩ from the SR into the cytosol, whereas relaxation is mediated by the rapid removal of cytosolic Ca 2ϩ , which is predominantly re-sequestered into the SR by the Ca 2ϩ pumps of the SERCA gene family.
In higher vertebrates, SERCA Ca 2ϩ -pump isoforms are encoded by three genes, recently designated ATP2A1-3 (reviewed in Refs. 1 and 2). Further isoform diversity at the protein level is created by alternative processing of the primary gene transcripts at a conserved 3Ј-terminal site. Alternative processing is regulated in a developmental or tissue-specific manner. SERCA1 is expressed specifically in adult (SERCA1a) or neonatal (SERCA1b) fast-twitch skeletal muscle. SERCA2a is expressed in the heart and in slow-twitch muscle, whereas SERCA2b is the main isoform expressed in smooth muscle and in all non-muscle tissues examined. SERCA3 isoforms are expressed in various non-muscle cells. Various pathologies have been linked to defects in SERCA-encoding genes. Mutations in ATP2A1, encoding SERCA1, cause an autosomal recessive form of Brody disease (3) , whereas the loss of one functional allele of ATP2A2 encoding SERCA2 causes Darier-White disease (4) . In addition, reduction in cardiac-specific SERCA2a function has been associated with relaxation abnormalities in heart failure (Ref. 2 and references therein). Mouse models with altered levels of SERCA2a or of its regulator phospholamban (PLB) further support a role for SERCA2a in cardiac function (5) (6) (7) (8) (9) (10) . Moreover, increasing contractility by alteration of SERCA2a or PLB levels in myocardium could prevent the onset of cardiac failure in different models of the disease (11, 12) . These studies carry the prospect that modulation of SERCA2a or PLB activity can correct cardiac dysfunction in heart failure. The nematode Caenorhabditis elegans is an established model organism amenable to genetic and pharmacological analysis. Here we report characterization of the unique C. elegans SERCA homologue. The two protein isoforms, CeSERCAa and CeSERCAb, show differential functional characteristics and expression patterns. Down-regulation of CeSERCA results in defects in various muscle and myoepithelial tissues, demonstrating an indispensable role for CeSERCA in behavior, growth, and reproduction.
EXPERIMENTAL PROCEDURES
Expression of CeSERCA in COS Cells-Standard molecular biological techniques were used to construct plasmids. A NotI-KpnI restriction fragment (3.2 kb) containing the entire coding sequence of CeSERCAb (Kohara clone yk75f8) was blunt-ended and ligated into the blunt-ended BamHI-XhoI sites of pcDNA3 mammalian expression vector (Invitrogen). The CeSERCAa expression vector was constructed by replacing the CeSERCAb-specific tail for a PCR-amplified CeSERCAa-specific tail by ApaI-BstXI swapping. Transient DNA transfections were carried out in COS-1 cells with FuGENE TM 6 transfection reagent (Roche Molecular Biochemicals) according to the manufacturer's instructions. Microsomes from COS-1 cells overexpressing CeSERCAa/b isoforms were prepared as described earlier (13) .
Immunochemistry-Antisera were raised to synthetic peptides CeSERa (VEAPIKDKRD) and CeSERb (AVVTPDKLHNEL) by EURO-GENTEC, Seraing, Belgium. The pan-specific SERCA antiserum 809-27 (14) was kindly provided by J. V. Møller (University of Aarhus, * This work was supported in part by the Vlaams Instituut voor de Bevordering van het Wetenschappelijk-Technologisch Onderzoek in de Industrie (IWT) and by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0137.00). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed. 1 The abbreviations used are: SR, sarcoplasmic reticulum; GFP, green fluorescent protein; PLB, phospholamban; SERCA, sarco-endoplasmic reticulum Ca 2ϩ -transport ATPase; kb, kilobase(s); PCR, polymerase chain reaction. Denmark). Immunocytochemical experiments on COS-1 cells transfected with CeSERCAa/b isoforms were performed as described by Wuytack et al. (15) . Cells were stained 60 h after transfection. Primary anti-SERCA antisera were used at 1:100 and 1:1000 dilutions. Stained samples were treated with ProLong TM anti-fade reagent (Molecular Probes Inc.) to retard photobleaching. Western blotting was performed as reported previously (15) .
Ca 2ϩ Uptake and Phosphorylation Assays-Oxalate-stimulated ATPdependent 45 Ca 2ϩ uptake in microsomal fractions was measured at 27°C by a Millipore filtration method as described earlier (16) . Phosphorylations were done as described in Verboomen et al. (17) . Microsomal fractions were incubated in phosphorylation buffer containing 1 mM EGTA or 0.1 mM EGTA ϩ 0.9 mM Ca Strains and Alleles-C. elegans strains were maintained according to Brenner (18) and grown at 20°C. sca-1(ok190) was back-crossed seven times against the wild-type strain N2 and unc-49(e382) using PCR to follow the lethal mutation.
Cloning and Transformation Rescue of sca-1-A genomic sca-1 subclone, pGK1, was generated by inserting a 14-kb SpeI fragment from the cosmid K11D9 into pUC18. A 3.3-kb MluI-SmaI fragment was removed to yield pGK7. This clone contains 5.6 kb of sequence upstream of the translational start codon and 1.1 kb of sequence downstream of the translational stop codon of CeSERCAa.
Germ-line transformation rescue of the sca-1(ok190) null mutant was performed by injecting pGK7 at 10 and 20 ng/l along with pRF4 (rol-6 D marker) and the pGK10 (P sca-1 ::GFP) construct described below. A total of 10 lines were established that all rescued sca-1(ok190). Isoformspecific constructs (pDW2651 and pDW2652) were made by inserting the pGK10 promoter fragment and the cDNAs amplified from the mammalian expression vectors into pPD49.26.
2 These constructs were injected at 20 ng/l. From each construct 5 lines were obtained that, all but one, rescued ok190.
Construction of Green Fluorescent Protein (GFP)
Reporter Genes-To construct P sca-1 ::GFP (pGK10), a 5.0-kb fragment of the sca-1 upstream sequence ending at the translational start site was amplified from pGK7 and cloned into the SalI and BamHI sites of pPD95.75. 2 For CeSERCAa::GFP (pGK26) and CeSERCAb::GFP (pGK27), standard overlap extension PCR was performed to obtain products consisting of three subfragments: the C terminus of the proper isoform, GFP, and the 3Ј-untranslated region of that isoform. These were swapped into pGK7 using ApaI-PacI for CeSERCAa and ApaI-SalI for CeSERCAb, respectively. Constructs were injected at 20 ng/l. For each construct at least three lines were obtained.
RNA Interference-The 727-base pair EcoRI-HindIII fragment from exon 5 was cloned into pGEM3 to yield pGK6. RNA was transcribed in vitro from linearized pGK6 using the MEGAscript™ SP6 and T7 kits (Ambion), mixed, and dissolved in injection buffer (66 mM potassium phosphate (pH 7.5), 10 mM potassium citrate (pH 7.5), 6.6% polyethylene glycol 3550). Double-stranded RNA was injected into gravid adults, which were transferred to fresh plates 3 h after injection to remove embryos resulting from eggs fertilized before the injection. Injections were done at three different times, and each time at least 10 animals were injected.
Thapsigargin-resistant Strains-The mutation F259V was introduced into pGK7 using the QuikChange site-directed mutagenesis Kit (Stratagene) with Pfu DNA polymerase and primers oGK33 (CAACA-GAAGTTGGACGAAGTCGGAGAGCAACTTTC) and oGK34 (GAAAG-TTGCTCTCCGACTTCGTCCAACTTCTGTTG). The resulting plasmid (pGK28) was able to rescue sca-1(ok190) (data not shown). pGK28 was injected at 20 ng/l in N2 together with 20 ng/l pGK10 and 160 ng/l pUC18. Three strains were obtained: UG528, UG529, and UG530. UG528 and UG530 showed comparable resistance to thapsigargin; UG529 was somewhat less resistant.
Thapsigargin Plate Assay-12-Well plates with standard NGM agar (2 ml) were seeded with a thin lawn of cold-sensitive OP50-derived bacteria that were completely covered with a 10-l drop of thapsigargin (Alomone Labs, Jerusalem, Israel) dissolved in Me 2 SO 1 day before the test. The thapsigargin concentrations mentioned in the text assume complete diffusion of thapsigargin in the plate. To follow the growth of wild-type and thapsigargin-resistant animals, thapsigargin plates were seeded with ϳ50 L1 larvae obtained after bleaching and hatching in M9, 4 wells/strain/concentration. The stage of each animal was determined after 3 days of growth at 20°C. As a way of quantifying growth, each stage was assigned an arbitrary value (1 for adult, 0.5 for L4, 0.25 for L3, and 0.125 for L2). The "relative growth score" reflects the average stage all animals reached. When all animals become adult, the resulting score is 1.0. When half of the animals reach the L3 and half reach the L4 stage of the resulting score becomes 0.375.
RESULTS
CeSERCA Is Highly Conserved-The C. elegans genome contains only one gene encoding a SERCA homologue. This gene was originally identified by the C. elegans sequencing consortium (19) and annotated K11D9.2. In this paper, we will refer to the gene as sca-1 and to the corresponding protein as CeSERCA. CeSERCA shows about 70% amino acid identity and 80% similarity to the three human SERCA proteins. The phosphorylation domains of CeSERCA and human SERCA2 share 81% amino acid identity, the ATP binding domains share 59% amino acid identity, and the anchor domain shares 67% amino acid identity. The predicted amino acid sequence of CeSERCA possesses all residues defined as essential for phosphorylation (Asp-351), ATP binding (such as Phe-487, Lys-515, and Lys-492) and Ca 2ϩ binding/translocation in membranespanning segments 4, 5, 6, and 8 (for review see e.g. Ref. 20) . C. elegans SERCA does not contain the putative cytosolic interaction site for phospholamban, which is found both in vertebrate SERCA1 and SERCA2 but is lacking in vertebrate SERCA3 and in other invertebrate SERCAs (21) . It should be noted in this respect that no gene encoding PLB or a PLB-like protein could be found in C. elegans nor has such a gene been reported in any other invertebrate.
The sca-1 gene consists of eight exons and seven introns (Fig.  1A) . The positions of four of these introns in the nematode gene are conserved in all three vertebrate SERCA genes; the worm introns 3, 4, 5, and 6 correspond to the vertebrate SERCA 2 A. Fire, J. Ahnn, G. Seydoux, and S. Xu, personal communication.
FIG. 1.
Gene structure of sca-1. A, the full genomic organization of the sca-1 rescuing clone. Up-and downstream sequences are depicted as a straight line, untranslated regions as empty boxes. Exons are numbered and depicted as filled boxes. The coding region shared by the two CeSERCA isoforms is in black, and the isoform-specific coding regions are in dark gray. The fragment removed in ok190 and the fragment used for RNA interference are indicated. B, GFP reporter constructs used in this study. GFP is denoted as a filled light gray box. Sequences derived from the genomic sca-1 clone as in A.
introns 1, 5, 16, and 19, respectively. The transcripts of the sca-1 gene, like those of the three vertebrate SERCA genes, can be alternatively spliced, whereby the position of the alternative intron is conserved as well. Alternative splicing of the sca-1 transcript follows a similar mode as that of vertebrate SERCA2, which differs from that of SERCA1 or SERCA3. In sca-1, exon seven contains an optional internal 5Ј splice donor site, which can be spliced to the 3Ј splice acceptor site, marking the beginning of exon eight (Fig. 1A) . Such a splicing results in the formation of the short isoform (1004 amino acids), which we name CeSERCAa following the nomenclature in the SERCA field. The absence of this splicing leads to expression of the CeSERCAb variant (1059 amino acids). As in vertebrate SERCA2b, the CeSERCAb-specific tail comprises a hydrophobic stretch (1006-SAISLLAWVSVT-LAYFAWMLG-1026) with the propensity to form an additional transmembrane domain. Four lines of evidence indicate that both predicted CeSERCA proteins are indeed expressed in C. elegans. First, multiple cDNA clones of both isoforms are present in the Kohara cDNA collection (www.ddbj.nig.ac.jp/htmls/ c-elegans/html/CE_INDEX.html). Second, both transcripts were detected using reverse transcription-PCR on whole worm mRNA. Third, both proteins were detected by Western blotting on fragmented membranes prepared from whole worms (Fig. 2) . Fourth, GFP reporter constructs specific for each of the splice variants were expressed in vivo (see Fig. 7 ).
CeSERCAa and CeSERCAb Function as P-type Ca 2ϩ
Pumps-COS-1 cells were transiently transfected with cDNAs encoding each CeSERCA isoform. Immunocytochemical staining with isoform-specific polyclonal antisera or with a polyclonal pan-specific SERCA antiserum revealed that both CeSERCA proteins were expressed at high levels and were properly targeted to the ER compartment (Fig. 3A) . Western blots of microsomes prepared from these cells showed immunoreactive bands with an electrophoretic mobility of around 100 kDa, with CeSERCAb showing a slightly higher apparent molecular mass than CeSERCAa (Fig. 3B) . From these blots it can also be concluded that in the COS cells the CeSERCAs were expressed at levels at least 10-fold higher than the endogenous SERCA2b. Microsomal vesicles were isolated from the transfected COS cells to measure the time course of oxalate-stimulated Ca 2ϩ uptake. Ca 2ϩ transport into the vesicles was strictly dependent on the presence of ATP. The apparent affinity for Ca 2ϩ (K m ) of CeSERCAa was found to be 2-fold lower than that of CeSERCAb (K m ϭ 0.80 versus 0.40 M; Fig. 4A ). This difference is similar to that seen for vertebrate SERCA2a and SERCA2b (17) . Thus, both the mode of splicing and its structural and functional consequences at the protein level appear to be evolutionarily conserved.
As other P-type ATPases (reviewed in Ref. 20) , CeSERCA formed a phosphoprotein intermediate (Fig. 4B) . Phosphorylation depended on the presence of Ca 2ϩ and was much more pronounced in microsomes from CeSERCA-expressing COS cells than in microsomes from untransfected controls, in concurrence with the strong overexpression of the CeSERCA isoforms in the COS cells.
C. elegans SERCA Is Essential for Larval Development-A deletion allele of the sca-1 gene was isolated using a PCR-based sib-selection protocol (kindly provided by the C. elegans knockout consortium). Subsequent sequence analysis revealed that this allele, designated ok190, lacked 12 base pairs of intron 4 and 1690 base pairs of exon 5 (Fig. 1A) . The deleted region encompasses the third and fourth transmembrane domain (the latter of which contains residues critical for Ca 2ϩ binding/ translocation), the ATP binding domain, and the phosphorylation domain including the aspartyl phosphorylation site, ascertaining that ok190 represents a sca-1 null allele.
Animals heterozygous for ok190 appeared as wild type. Animals that were homozygous for ok190, however, arrested in the first larval (L1) stage, showed slow and irregular pharyngeal pumping and sluggish body movement, and became constipated (Fig. 5A) . Their body cavity became filled with fluid, indicative of defective osmo-regulation. ok190 larvae rescued by the wild-type sca-1 gene on an extra-chromosomal transgene developed into apparently wild-type adults that were, however, sterile or produced very few offspring. The gonads of these adults contained endomitotic oocytes, indicative of failing ovulation (Fig. 5B) .
C. elegans SERCA Is Essential for Embryonic Development-To perform RNA interference (22), double-stranded RNA was prepared in vitro from a 727-base pair genomic fragment (Fig. 1A) and injected into the gonadal syncytium of healthy wild-type gravid adults. Within 24 h the injected animals became sterile (Fig. 5D) .
The progeny of injected animals was severely affected. About half of them successfully completed embryonic development but then arrested at the L1 stage, closely resembling homozygous ok190 larvae. The other half of the progeny arrested already during embryogenesis, usually at the 2-3-fold stage (Fig. 5C) . Similar results were reported by Cho et al. (23) , although embryonic defects generally occurred at an earlier stage.
C. elegans SERCA Is Inhibited by Thapsigargin-Thapsigargin is a highly potent and highly specific inhibitor of SERCA pumps (24, 25) . L4 larvae or young adults that were transferred to thapsigargin-containing plates acutely and completely suppressed pharyngeal pumping (Table I ). The effect was reversible; after 1 h, pharyngeal pumping resumed, albeit slower and irregular. In addition, thapsigargin affected animal movement and defecation cycles ( Table I ). The animals became small, pale, and thin as a consequence of limited food intake and displayed a protruding vulva ( Fig. 6A; Table I ). Often the gonads were malformed and contained endomitotic oocytes or oocytes with multiple nuclei, resulting in a reduced production of progeny (Fig. 6C) . Thapsigargin also affected growth. Wildtype L1 larvae essentially arrested or died at the L3 or L4 stage when transferred to plates containing 1.25 M thapsigargin or higher, whereas L1 larvae developed normally into healthy, gravid adults at less than 1.25 M thapsigargin (Fig. 6D) .
Two lines of evidence support the view that CeSERCA is the in vivo target for thapsigargin and that the binding site for thapsigargin is conserved in CeSERCA. First, the epoxide derivative of thapsigargin did not cause any defect under the same experimental conditions, not even at 64-fold higher concentrations (data not shown). As the result of a very small structural change, thapsigargin epoxide has a SERCA affinity of at least 5 orders of magnitude lower than thapsigargin and, thus, serves as a negative control for thapsigargin inhibition (26) . Second, animals expressing CeSERCA with a mutated thapsigargin-binding site showed greatly reduced sensitivity to thapsigargin. It was reported that F256V-substituted avian SERCA1 required 40-fold higher concentrations of thapsigar- a Wild-type N2 animals and N2 expressing CeSERCA F259V were grown on standard plates and transferred to plates with or without thapsigargin as young adults. Complete cessation of pharyngeal pumping was determined after 30 min, loopy movement after 4 h, reduced fertility, gut morphology and protruding vulva after 24 h. b Each datapoint represents approximately 100 animals.
gin to inhibit Ca 2ϩ uptake than wild-type SERCA1 (27) . We introduced the homologous F259V mutation into the rescuing CeSERCA construct described above and established transgenic strains carrying this construct on an extrachromosomal array. Transgenic young adults were considerably less responsive to thapsigargin than wild-type young adults (Fig. 6B and Table I ). Also, transgenic L1 larvae developed into healthy, gravid adults at high thapsigargin concentrations that caused developmental arrest and lethality of wild-type or non-transgenic L1 (Fig. 6D) .
C. elegans SERCA Is Expressed in Contractile and Noncontractile Tissue-To determine the expression pattern of sca-1, we made a number of GFP reporter constructs. The isoform-specific reporter constructs CeSERCAa::GFP and CeSERCAb::GFP were obtained by insertion of GFP (28) at the C-terminal end of either coding region in the rescuing sca-1 genomic clone (Fig. 1B) . A third construct, P sca-1 ::GFP, contained sca-1 upstream sequence transcriptionally fused to GFP (Fig. 1B) .
All three reporter constructs were expressed in all major contractile tissues, starting during embryogenesis and continuing until adulthood (Fig. 7 and data not shown) . Fluorescence was particularly pronounced in striated muscle (body wall muscles used for locomotion), non-striated muscle (pharyngeal muscles used for pharyngeal pumping, vulval and uterine muscles used for egg laying, the sphincter muscle and anal depressor used for defecation), and in myoepithelial cells (gonadal sheath cells used for ovulation). Furthermore, all three constructs showed expression in the intestine.
Some cells expressed CeSERCAb::GFP but not CeSERCAa::GFP. These include the somatic cells of the spermatheca and the excretory canal and the uterine sheath cells (Fig.  7, B-D) . No cells were found that expressed CeSERCAa::GFP but not CeSERCAb::GFP.
Fluorescence from P sca-1 ::GFP was evenly distributed over the cytosol. However, both CeSERCAa::GFP and CeSERCAb::GFP showed specific subcellular localization. Both fusion proteins were found in a tubular meshwork that was most distinct in the body wall muscle cells. This staining was continuous with staining at or near the dense bodies, structures functionally analogous to vertebrate Z-lines (Fig.  7, E and F) . In body wall muscle cells and other cells, staining was also often localized in internal vesicles and membranelike structures, including the nuclear envelope. 
DISCUSSION
In this paper we have described the C. elegans SERCA gene sca-1 and its two protein products. Alternative splicing occurs at a homologous position in the worm transcript as in vertebrate SERCA1-3 transcripts, according to a mode typical for SERCA2. It leads to the production of two protein variants, CeSERCAa and CeSERCAb, which structurally and functionally resemble the SERCA2a and SERCA2b isoforms, pointing to an evolutionarily conserved mechanism and functional significance of the isoform diversity. Both CeSERCA isoforms transported Ca 2ϩ into the microsomal vesicles of COS-1 cells in an ATP-dependent and oxalate-stimulated manner, which was associated with the formation of a Ca 2ϩ -dependent phosphoprotein intermediate. Similarly to mammalian SERCA2a and SERCA2b, the longer b isoform showed a 2-fold higher apparent affinity for Ca 2ϩ than the a isoform. However, in contrast to SERCA2 expression pattern, the two CeSERCA isoforms were expressed in a highly overlapping pattern.
We employed three complementary approaches to inactivate CeSERCA. Direct gene targeting, RNA interference, and treatment with the SERCA-specific inhibitor thapsigargin all resulted in developmental arrest and lethality. The observation that RNA interference caused embryonic lethality, whereas the ok190 null allele caused larval lethality, argues for a maternal component of CeSERCA expression, which is required during early embryogenesis, and a zygotic component, which is required during larval development. ok190 embryos receive CeSERCA from their heterozygous mothers but fail to produce CeSERCA themselves and, hence, arrest as L1 larvae. Injection of double-stranded RNA into wild-type mothers already removes the maternal component and, hence, results in embryonic arrest.
Besides its absolute requirement for normal development, inhibition of CeSERCA resulted in a variety of behavioral defects, reflecting the widespread expression of CeSERCA. The pumping and movement defects in ok190 larvae and after thapsigargin treatment show that Ca 2ϩ from internal stores plays an important role in pharyngeal and body wall muscle activity. Both pharyngeal pumping and locomotion are impaired but not eliminated in animals deficient for CeSERCA. Apparently, Ca 2ϩ release from intracellular stores is required for full muscle function but is not essential for excitation-contraction coupling, as is also suggested by the relatively mild phenotypes observed in mutants of the main Ca 2ϩ release channel of the SR, the ryanodine receptor (29, 30) . Perhaps Ca 2ϩ entry through the plasma membrane is sufficient to induce pharyngeal and body wall muscle contraction. The smaller size and higher surface-to-volume ratio compared with vertebrate muscle cells could make nematode muscle cells relatively less dependent on internal Ca 2ϩ stores. Furthermore, the diminished Ca 2ϩ -loading state of internal stores may increase Ca 2ϩ entry at the plasma membrane via store-activated Ca 2ϩ entry. CeSERCA-deficient animals show defective defecation, a process that is coordinated by inositol-trisphosphate receptormediated Ca 2ϩ oscillations generated in the posterior intestinal cells (31) . The defecation defects found in CeSERCA-deficient animals could therefore be caused by the absence of these Ca 2ϩ oscillation cycles by defective body wall or enteric muscle contraction or both. The process of ovulation requires the concerted action of oocyte signaling, spermathecal dilation, and sheath cell contraction (32, 33) . Mutants of two other Ca 2ϩ -handling proteins, the inositol trisphosphate receptor, expressed in the spermatheca (34) , and troponin T, expressed in the sheath cells (35) , also display ovulation defects. Any of these events could be perturbed in CeSERCA-deficient animals. Osmo-regulation is mediated by the excretory canal. Dysfunction of this cell, which expresses CeSERCAb, is therefore the likely cause of the osmo-regulatory defects found in CeSERCA-deficient animals.
Thus, loss of CeSERCA activity leads to a variety of phenotypes that could be used as a starting point for further analysis. C. elegans is a model organism amenable to high-throughput genetic and pharmacological screening. Because SERCA is likely to be a difficult target for classical in vitro drug screening, C. elegans-based models could prove to be particularly useful in the identification of compounds against SERCA-related diseases, such as heart disease.
